| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Senescence and cell death pathways and their role in cancer therapeutic outcome. | Curr Med Chem | 2009 | 0.96 |
| 2 | Perspectives in biomolecular therapeutic intervention in cancer: from the early to the new strategies with type I interferons. | Curr Med Chem | 2007 | 0.95 |
| 3 | Interferon-beta induces S phase slowing via up-regulated expression of PML in squamous carcinoma cells. | Oncogene | 2000 | 0.93 |
| 4 | Retinoic acid and IFN inhibition of cell proliferation is associated with apoptosis in squamous carcinoma cell lines: role of IRF-1 and TGase II-dependent pathways. | Cell Growth Differ | 1997 | 0.90 |
| 5 | Cancer regulator microRNA: potential relevance in diagnosis, prognosis and treatment of cancer. | Curr Med Chem | 2012 | 0.87 |
| 6 | Inhibition of protein phosphorylation modulates expression of the Jak family protein tyrosine kinases. | J Virol | 1995 | 0.81 |
| 7 | Hemin inhibits the interferon-beta-induced antiviral state in established cell lines. | J Interferon Cytokine Res | 1995 | 0.76 |